ACM
TNYA icon

ADAR1 Capital Management’s Tenaya Therapeutics TNYA Stock Holding History

ADAR1 Capital Management’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.15M Buy
1,555,500
+47,700
+3% +$36.2K 0.05% 163
2026
Q1 		$1.04M Buy
1,507,800
+2,500
+0.2% +$1.84K 0.06% 155
2025
Q4 		$1.07M Buy
+1,505,300
New +$2.05M 0.08% 128

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ADAR1 Capital Management's TNYA Position: Q2 2026 in Review

ADAR1 Capital Management increased its Tenaya Therapeutics (TNYA) stake by 3.2% in Q2 2026, buying an estimated $36.2K and bringing the position to 1,555,500 shares worth $1.15M. The position accounts for 0.05% of the portfolio, ranked #163.

ADAR1 Capital Management first reported a position in TNYA in Q4 2025 and has held it in 3 quarters since. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • ADAR1 Capital Management held 1,555,500 shares of Tenaya Therapeutics worth $1.15M as of Q2 2026.
  • ADAR1 Capital Management bought 47,700 Tenaya Therapeutics shares in Q2 2026, an estimated $36.2K.
  • Tenaya Therapeutics made up 0.05% of ADAR1 Capital Management's portfolio in Q2 2026, its #163 holding.
  • ADAR1 Capital Management first reported a position in Tenaya Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.